Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.
Journal article
Raman B., (2023), JACC Cardiovasc Imaging
Erratum for: Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID.
Journal article
Grist JT. et al, (2023), Radiology, 309
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Journal article
Taquet M. et al, (2023), Nat Med
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
Journal article
Coleman JA. et al, (2023), International Journal of Cardiovascular Imaging, 1 - 18
Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
Journal article
Roca-Fernandez A. et al, (2023), J Hepatol
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Journal article
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Journal article
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
Journal article
Farrant J. et al, (2023), Heart
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study.
Journal article
Finnigan LEM. et al, (2023), EClinicalMedicine, 59
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
Journal article
Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Journal article
Jackson C. et al, (2023), Lancet Respir Med
3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry.
Journal article
Heydari B. et al, (2023), JACC Cardiovasc Imaging, 16, 478 - 491
Acute changes in myocardial tissue characteristics during hospitalization in patients with COVID-19.
Journal article
Shanmuganathan M. et al, (2023), Front Cardiovasc Med, 10
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19.
Journal article
Daines L. et al, (2023), ERJ Open Res, 9
Editorial: Post-COVID-19 cardiovascular sequelae.
Journal article
Condurache D-G. et al, (2023), Front Cardiovasc Med, 10
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.
Journal article
Raisi-Estabragh Z. et al, (2022), Heart, 109, 119 - 126
Altered lung physiology in two cohorts post COVID-19 infection as assessed using computed cardiopulmonography.
Journal article
Magor-Elliott SRM. et al, (2022), J Appl Physiol (1985)